$GTCH In order to assist with the world's current situation, GBT/Tokenize has decided to introduce an initial release of qTerm. The early release of the product will include body temperature, heart rate and blood oxygen level features and is targeted to be released by the end of this year. These three (3) vitals measurements are essential to assist with the pandemic crisis since they provide important health factors for early viral infection detection. The Blood Pressure feature is planned to be released in qTerm second release, planned for Q1 2021.
"Our qTerm device was planned to provide major human vitals, one of them is blood pressure. We decided to rush our first version to the market in order to assist with the global pandemic. As qTerm general development is continuing we are now developing its originally planned feature; blood pressure. Using a digital embedded sensor electronic system, and machine-learning algorithms we develop an embedded optical based analysis system to measure blood pressure. This miniature system will be based on photophlethysmography (PPG) method and installed within our qTerm medical device," stated Danny Rittman, GBT’s CTO. "qTerm will measure the amount of light that is absorbed or reflected by blood vessels in human tissues, calculating responsive changes in the blood's volume. The sensor coverage area includes veins, arteries, and numerous capillaries. Software algorithm will calculate and conclude the numerical results. qTerm will include blood oxygen level, heart rate, body temperature and blood pressure vitals measurements and all with a touch of a finger, a none-invasive product. Users will be able to potentially monitor their health, potentially identify early signs of health issues, and take appropriate care. Blood pressure is a critical vital to address proper treatment and management. Many medical conditions require this data and qTerm will be offering an easy, convenient measurement capability that will enable users to take the time and potentially monitor their health frequently. No bulkier cuffs and discomfort measurement devices, but a simple non-invasive touch of a finger will make the process of blood pressure measurement comfortable, easier and faster. High blood pressure is associated with many chronic disease conditions, and is a major source of mortality and disabilities around the world. The device mobile app will support the additional feature by recording and analyzing the data. We strongly believe that this feature will be a significant addition to the qTerm device, making it a comprehensive, easy for use, mainly intuitive, medical device. We plan to expand the device furthermore the future, adding more features and AI analysis capabilities," continued Dr. Rittman.
https://www.otcmarkets.com/stock/GTCH/news/st...id=1733675
"Our qTerm device was planned to provide major human vitals, one of them is blood pressure. We decided to rush our first version to the market in order to assist with the global pandemic. As qTerm general development is continuing we are now developing its originally planned feature; blood pressure. Using a digital embedded sensor electronic system, and machine-learning algorithms we develop an embedded optical based analysis system to measure blood pressure. This miniature system will be based on photophlethysmography (PPG) method and installed within our qTerm medical device," stated Danny Rittman, GBT’s CTO. "qTerm will measure the amount of light that is absorbed or reflected by blood vessels in human tissues, calculating responsive changes in the blood's volume. The sensor coverage area includes veins, arteries, and numerous capillaries. Software algorithm will calculate and conclude the numerical results. qTerm will include blood oxygen level, heart rate, body temperature and blood pressure vitals measurements and all with a touch of a finger, a none-invasive product. Users will be able to potentially monitor their health, potentially identify early signs of health issues, and take appropriate care. Blood pressure is a critical vital to address proper treatment and management. Many medical conditions require this data and qTerm will be offering an easy, convenient measurement capability that will enable users to take the time and potentially monitor their health frequently. No bulkier cuffs and discomfort measurement devices, but a simple non-invasive touch of a finger will make the process of blood pressure measurement comfortable, easier and faster. High blood pressure is associated with many chronic disease conditions, and is a major source of mortality and disabilities around the world. The device mobile app will support the additional feature by recording and analyzing the data. We strongly believe that this feature will be a significant addition to the qTerm device, making it a comprehensive, easy for use, mainly intuitive, medical device. We plan to expand the device furthermore the future, adding more features and AI analysis capabilities," continued Dr. Rittman.
https://www.otcmarkets.com/stock/GTCH/news/st...id=1733675
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
